Leal Therapeutics
Biotech · Private
Novel therapeutics targeting central nervous system disorders
lealtx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 0 granted · 40 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2074 | Key Health Institute of Edmond, LLC | — | $100K |
| 2075 | RGENIX, INC. | — | — |
| 2076 | Outpost Intros Inc. | — | $475K |
| 2077 | Leal Therapeutics | — | — |
| 2078 | PHOENIX PHARMALABS, INC. | — | $3.5M |
| 2079 | STEMCELLLIFE LLC | — | — |
| 2080 | Synergyan, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Press
Leal Therapeutics Announces $30 Million Series A Extension and Initiation of Phase 1b/2a Clinical Trial of LTX-001 in SchizophreniaAssociated Press
Patents
- Use Of Small Molecule Glutaminase Inhibitors For Treating Age-related Disordersapplication
- Small Molecule Inhibitors Of Glutaminaseapplication
- Compositions And Methods For Modulating GLS1application
- Compositions And Methods For Modulating C3application
- Use Of Small Molecule Glutaminase Inhibitors For Treating Age-related Disordersapplication
- Use Of Small Molecule Glutaminase Inhibitors For Treating Age-related Disordersapplication
- Use Of Small Molecule Glutaminase Inhibitors For Treating Age-related Disordersapplication
- Compositions And Methods For Modulating SPTLC2application
- Use Of Small Molecule Glutaminase Inhibitors For Treating Age-related Disordersapplication
- Compositions And Methods For Modulating Apoeapplication
- Small Molecule Inhibitors Of Glutaminaseapplication
- Small Molecule Inhibitors Of Glutaminaseapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.